Sphingolipid biosynthetic inhibitor L-Cycloserine prevents oxidative-stress-mediated death in an in vitro model of photoreceptor-derived 661W cells
Experimental Eye Research · 2024
DOI: 10.1016/j.exer.2024.109852 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Eye Research, 2024. Verfasst von Faiza Tahia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN, 38163, USA; Department of Ophthalmology, Universit…. Hauptthemen laut MEDLINE: Oxidative Stress, Cycloserine, Ceramides, Sphingolipids. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, BLRD VA, NIDDK NIH HHS.
Abstract (Originalsprache)
Oxidative stress plays a pivotal role in the pathogenesis of several neurodegenerative diseases. Retinal degeneration causes irreversible death of photoreceptor cells, ultimately leading to vision loss. Under oxidative stress, the synthesis of bioactive sphingolipid ceramide increases, triggering apoptosis in photoreceptor cells and leading to their death. This study investigates the effect of L-Cycloserine, a small molecule inhibitor of ceramide biosynthesis, on sphingolipid metabolism and the protection of photoreceptor-derived 661W cells from oxidative stress. The results demonstrate that treatment with L-Cycloserine, an inhibitor of Serine palmitoyl transferase (SPT), markedly decreases bioactive ceramide and associated sphingolipids in 661W cells. A nontoxic dose of L-Cycloserine can provide substantial protection of 661W cells against H2O2-induced oxidative stress by reversing the increase in ceramide level observed under oxidative stress conditions. Analysis of various antioxidant, apoptotic and sphingolipid pathway genes and proteins also confirms the ability of L-Cycloserine to modulate these pathways. Our findings elucidate the generation of sphingolipid mediators of cell death in retinal cells under oxidative stress and the potential of L-Cycloserine as a therapeutic candidate for targeting ceramide-induced degenerative diseases by inhibiting SPT. The promising therapeutic prospect identified in our findings lays the groundwork for further validation in in-vivo and preclinical models of retinal degeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN, 38163, USA; Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
- Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
- Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN, 38163, USA; Memphis VA Medical Center, Memphis, TN, 38104, USA.
- Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
- Plough Center for Sterile Drug Delivery Solutions, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
- Office of Executive Vice Chancellor and Chief Operations Officer, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
Förderung
- NEI NIH HHS
- BLRD VA
- NIDDK NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- NIAID NIH HHS
- National Institutes of Health
- US Department of Defense
Zitieren
APA
Tahia, F., Basu, S. K., Prislovsky, A., Mondal, K., Ma, D., Kochat, H., Brown, K., Stephenson, D. J., Chalfant, C. E., & Mandal, N. (2024). Sphingolipid biosynthetic inhibitor L-Cycloserine prevents oxidative-stress-mediated death in an in vitro model of photoreceptor-derived 661W cells. Experimental Eye Research. https://doi.org/10.1016/j.exer.2024.109852
Vancouver
Tahia F, Basu SK, Prislovsky A, Mondal K, Ma D, Kochat H, et al. Sphingolipid biosynthetic inhibitor L-Cycloserine prevents oxidative-stress-mediated death in an in vitro model of photoreceptor-derived 661W cells. Experimental Eye Research. 2024. doi:10.1016/j.exer.2024.109852
BibTeX
@article{Tahia2024,
author = {Tahia, Faiza and Basu, Sandip K and Prislovsky, Amanda and Mondal, Koushik and Ma, Dejian and Kochat, Harry and Brown, Kennard and Stephenson, Daniel J and Chalfant, Charles E and Mandal, Nawajes},
title = {Sphingolipid biosynthetic inhibitor L-Cycloserine prevents oxidative-stress-mediated death in an in vitro model of photoreceptor-derived 661W cells},
journal = {Experimental Eye Research},
year = {2024},
doi = {10.1016/j.exer.2024.109852}
}
EUVIMED